STAMPEDE at the GU ASCO conference

STAMPEDE had a good presence at the recent GU ASCO (Genitourinary American Society of Clinical Oncology) conference where our Chief Investigator Professor Nick James presented posters for two STAMPEDE papers, both of which should be published soon. In the mean time please take a look at the GU ASCO abstracts for each paper here: http://bit.ly/xIDtbF

 New Abiraterone Arm  launched on Tuesday 15^th November

Following recent communication, you will be aware that the STAMPEDE trial protocol has recently undergone a substantial amendment, primarily to incorporate a new trial arm, Arm G = Hormone Therapy + Abiraterone. We are pleased to announce that we went live with the new 5-arm design on Tuesday 15th November and the Beatson Cancer Centre was the first to draw arm G when randomising a patient! 

The latest version of the protocol is version 8.0 2^nd Sep 2011. Please click on the links below to access the following documents:

STAMPEDE protocol version 8.0 

STAMPEDE protocol appendices version 8.0 

Version 8.0 approval letters from MHRA^* and the main REC

Separated Word versions of the updated PIS, consent form and GP letter

Please contact the MRC CTU for the Annex 2 Notification of amendment form

From this point Tuesday 15th November, only centres that have received and submitted to the MRC CTU R&D approval for version 8.0 of the trial will be able to participate and therefore it is really important that all centres look to process this amendment as soon as possible, if not completed already.

Please do not hesitate to contact us at the MRC CTU if you require any further information.

MRC Clinical Trials Unit, Aviation House, 125 Kingsway, London, WC2B 6NH

                                                                       stampede@ctu.mrc.ac.uk